Skip to main content
SpringerLink
Log in

Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

An Erratum to this article was published on 29 May 2014

Abstract

Background and aims

To assess work disability (WD) rates in an inflammatory bowel disease (IBD) cohort involving patients with Crohn’s disease (CD) or ulcerative colitis (UC) cohort and to identify possible clinical or demographic factors associated with WD. To our knowledge, this is the first study from Eastern Europe that has estimated indirect costs in IBD.

Methods

Data from 443 (M/F: 202/241, CD/UC: 260/183, mean age: 35.5 (CD) and 40.5 (UC) years, biological drug exposure 31.2/11.5 %) consecutive patients were included. WD data were collected by questionnaire and the work productivity and activity impairment instrument. Disability pension (DP) rates in the general population were retrieved from public databases.

Results

The overall DP rate in this IBD population was 32.3 %, with partial disability in 24.2 %. Of all DP events, 88.8 % were directly related to IBD. Overall, full DP was more prevalent in IBD (RR: 1.51, p < 0.001) and CD (RR: 1.74, p < 0.001) but not in UC compared to the general population and also in CD compared to UC (OR 1.57, p = 0.03). RR for full DP was increased only in young CD patients (RR<35 year olds: 9.4; RR36–40 year olds: 9.4 and 5.6, p < 0.01 for both). In CD, age group, previous surgery, disease duration, frequent relapses, and the presence of arthritis/arthralgia were associated with an increased risk for DP. Among employed patients, absenteeism and presenteeism was reported in of 25.9 and 60.3 % patients, respectively, leading to a 28 % loss of work productivity and a 32 % activity loss, and was associated with disease activity and age group. Average cost of productivity loss due to disability and sick leave with a human capital approach was 1,450 and 430 €/patient/year in IBD, respectively (total productivity loss 1,880 €/patient/year), the costs of presenteeism were 2,605 (SD = 2,770) and 2,410 (SD = 2,970) €/patient/year in CD and UC, respectively.

Conclusion

Risk of DP was highly increased in young CD patients (sixfold to ninefold). Previous surgery and presence of arthritis/arthralgia was identified as risk factors for DP. Work productivity is significantly impaired in IBD and is associated with high productivity loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Miheller, P., Kiss, L.S., Juhasz, M., Mandel, M., Lakatos, P.L.: Recommendations for identifying Crohn’s disease patients with poor prognosis. Expert Rev. Clin. Immunol. 9(1), 65–75 (2013)

    Article  CAS  PubMed  Google Scholar 

  2. Kiss, L.S., Lakatos, P.L.: Natural history of ulcerative colitis: current knowledge. Curr. Drug Targets 12(10), 1390–1395 (2011)

    Article  CAS  PubMed  Google Scholar 

  3. Burisch, J., Jess, T., Martinato, M., Lakatos, P.L., ECCO -EpiCom: The burden of inflammatory bowel disease in Europe. J. Crohns Colitis 7(4), 322–337 (2013)

    Article  PubMed  Google Scholar 

  4. Bouguen, G., Levesque, B.G., Feagan, B.G., Kavanaugh, A., Peyrin-Biroulet, L., Colombel, J.F., Hanauer, S.B., Sandborn, W.J.: Treat to target: a proposed new paradigm for the management of Crohn’s disease. Clin. Gastroenterol. Hepatol. (2013). doi:10.1016/j.cgh.2013.09.006

    Google Scholar 

  5. Bernstein, C.N., Loftus Jr, E.V., Ng, S.C., Lakatos, P.L., Moum, B.: Hospitalisations and surgery in Crohn’s disease. Gut 61(4), 622–629 (2012)

    Article  PubMed  Google Scholar 

  6. Boonen, A., Dagnelie, P.C., Feleus, A., Hesselink, M.A., Muris, J.W., Stockbrügger, R.W., Russel, M.G.: The impact of inflammatory bowel disease on labor force participation: results of a population sampled case–control study. Inflamm. Bowel Dis. 8, 382–389 (2002)

    Article  PubMed  Google Scholar 

  7. Ananthakrishnan, A.N., Weber, L.R., Knox, J.F., Skaros, S., Emmons, J., Lundeen, S., Issa, M., Otterson, M.F., Binion, D.G.: Permanent work disability in Crohn’s disease. Am. J. Gastroenterol. 103(1), 154–161 (2008)

    Article  PubMed  Google Scholar 

  8. Bernklev, T., Jahnsen, J., Henriksen, M., Lygren, I., Aadland, E., Sauar, J., Schulz, T., Stray, N., Vatn, M., Moum, B.: Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 12(5), 402–412 (2006)

    Article  PubMed  Google Scholar 

  9. Høivik, M.L., Moum, B., Solberg, I.C., Henriksen, M., Cvancarova, M., Bernklev, T., IBSEN Group: Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut 62(3), 368–375 (2013)

    Article  PubMed  Google Scholar 

  10. van der Valk, M.E., Mangen, M.J., Leenders, M., Dijkstra, G., van Bodegraven, A.A., Fidder, H.H., de Jong, D.J., Pierik, M., van der Woude, C.J., Romberg-Camps, M.J., Clemens, C.H., Jansen, J.M., Mahmmod, N., van de Meeberg, P.C., van der Meulen-de Jong, A.E., Ponsioen, C.Y., Bolwerk, C.J., Vermeijden, J.R., Siersema, P.D., van Oijen, M.G., Oldenburg, B., on behalf of the COIN study group and the Dutch Initiative on Crohn and Colitis: Risk factors of work disability in patients with inflammatory bowel disease—a Dutch nationwide web-based survey: work disability in inflammatory bowel disease. J. Crohns Colitis (2013). doi:10.1016/j.crohns.2013.11.019

    PubMed  Google Scholar 

  11. Siebert, U., Wurm, J., Gothe, R.M., Arvandi, M., Vavricka, S.R., von Känel, R., Begré, S., Sulz, M.C., Meyenberger, C., Sagmeister, M., Swiss, I.B.D., Cohort Study Group: Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study. Inflamm. Bowel Dis. 19(4), 847–855 (2013)

    Article  PubMed  Google Scholar 

  12. Stjernman, H., Tysk, C., Almer, S., et al.: Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn’s disease. Eur. J. Gastroenterol. Hepatol. 23, 671–679 (2011)

    Article  PubMed  Google Scholar 

  13. Gibson, P.R., Vaizey, C., Black, C.M., Nicholls, R., Weston, A.R., Bampton, P., Sparrow, M., Lawrance, I.C., Selby, W.S., Andrews, J.M., Walsh, A.J., Hetzel, D.J., Macrae, F.A., Moore, G.T., Weltman, M.D., Leong, R.W., Fan, T.: Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. J. Crohns Colitis (2013). doi:10.1016/j.crohns.2013.11.017

    Google Scholar 

  14. Israeli, E., Graff, L.A., Clara, I., Walker, J.R., Lix, L.M., Targownik, L.E., Bernstein, C.N.: Low prevalence of disability among patients with inflammatory bowel diseases a decade after diagnosis. Clin. Gastroenterol. Hepatol. (2013). doi:10.1016/j.cgh.2013.12.009

    Google Scholar 

  15. Lennard-Jones, J.E.: Classification of inflammatory bowel disease. Scand. J. Gastroenterol. 24(suppl 170), 2–6 (1989)

    Article  Google Scholar 

  16. Silverberg, M.S., Satsangi, J., Ahmad, T., Arnott, I.D., Bernstein, C.N., Brant, S.R., Caprilli, R., Colombel, J.F., Gasche, C., Geboes, K., Jewell, D.P., Karban, A., Loftus Jr, E.V., Peña, A.S., Riddell, R.H., Sachar, D.B., Schreiber, S., Steinhart, A.H., Targan, S.R., Vermeire, S., Warren, B.F.: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can. J. Gastroenterol. 19(Suppl A), 5–36 (2005)

    Google Scholar 

  17. Stange, E.F., Travis, S.P.L., Vermeire, S., Beglinger, C., Kupcinkas, L., Geboes, K., Barakauskiene, A., Villanacci, V., Von Herbay, A., Warren, B.F., Gasche, C., Tilg, H., Schreiber, S.W., Schölmerich, J., Reinisch, W., European Crohn’s and Colitis Organisation: European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 55(suppl 1), 11–15 (2006)

    Google Scholar 

  18. Best, W.R., Becktel, J.M., Singleton, J.W., Kern Jr, F.: Development of a Crohn’s disease activity index: national cooperative Crohn’s disease study. Gastroenterology 70, 439–444 (1976)

    CAS  PubMed  Google Scholar 

  19. Vermiere, S., Schreiber, S., Sandborn, W.J., Dubois, C., Rutgeerts, P.: Correlation between the Crohn’s disease activity and harvey-bradshaw indices in assessing Crohn’s disease severity. Clin. Gastroenterol. Hepatol. 8, 357–363 (2010)

    Article  Google Scholar 

  20. Schroeder, K.W., Tremaine, W.J., Ilstrup, D.M.: Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N. Engl. J. Med. 317, 1625–1629 (1987)

    Article  CAS  PubMed  Google Scholar 

  21. Reilly, M.C., Zbrozek, A.S., Dukes, E.M.: The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4(5), 353–365 (1993)

    Article  CAS  PubMed  Google Scholar 

  22. Reilly Associates’s WPAI translations webpage (2014). http://www.reillyassociates.net/WPAI_Translations.html. Accessed 18.01.2014

  23. Hungarian Central Administration of National Pension Insurance webpage (2014). http://ww.onyf.hu/index.php?module=news&action=getfile&fid=9762&rand=51d06e367983259f36f1f0e73a25cb4b. Accessed 18.01.2014

  24. Hungarian Central Administration of National Pension Insurance webpage (2014). https://www.onyf.hu/index.php?module=news&action=getfile&fid=9763&rand=24d24e51f4056da48ae0e96edd6743b0. Accessed 18.01.2014

  25. Koopmanschap, M.A., Rutten, F.F.: A practical guide for calculating indirect costs of disease. Pharmacoeconomics 10(5), 460–466 (1996)

    Article  CAS  PubMed  Google Scholar 

  26. Koopmanschap, M.A., Rutten, F.F., van Ineveld, B.M., van Roijen, L.: The friction cost method for measuring indirect costs of disease. J. Health Econ. 14(2), 171–189 (1995)

    Article  CAS  PubMed  Google Scholar 

  27. Lofland, J.H., Pizzi, L., Frick, K.D.: A review of health-related workplace productivity loss instruments. Pharmacoeconomics 22(3), 165–184 (2004)

    Article  PubMed  Google Scholar 

  28. Brodszky, V., Bálint, P., Géher, P., Hodinka, L., Horváth, G., Koó, É., Péntek, M., Polgár, A., Seszták, M., Szántó, S., Ujfalussy, I., Gulácsi, L.: Disease burden of psoriatic arthritis compared to rheumatoid arthritis. Hung. Exp. Rheumatol. Int. 30(2), 199–205 (2009)

    Article  Google Scholar 

  29. Péntek, M., Kobelt, G., Czirják, L., Szekanecz, Z., Poór, G., Rojkovich, B., Polgár, A., Genti, G., Kiss, C.G., Brodszky, V., Májer, I., Gulácsi, L.: Costs of rheumatoid arthritis in Hungary. J. Rheumatol. 34(6), 1437 (2007)

    PubMed  Google Scholar 

  30. Filipovic, I., Walker, D., Forster, F., Curry, A.S.: Quantifying the economic burden of productivity loss in rheumatoid arthritis. Rheumatology 50(6), 1083–1090 (2011)

    Article  PubMed  Google Scholar 

  31. Puolakka, K., Kautiainen, H., Pekurinen, M., Möttönen, T., Hannonen, P., Korpela, M., Hakala, M., Arkela-Kautiainen, M., Luukkainen, R., Leirisalo-Repo, M., FIN-RACo Trial Group: Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients’ sickness absence and gross income: experience from the FIN-RACo trial. Ann. Rheum. Dis. 65(7), 899–904 (2006)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Verstappen, S.M., Boonen, A., Verkleij, H., Bijlsma, J.W., Buskens, E., Jacobs, J.W., Utrecht Rheumatoid Arthritis Cohort Study Group: Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Ann. Rheum. Dis. 64(12), 1754–1760 (2005)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Gulácsi, L., Orlewska, E., Péntek, M.: Health economics and health technology assessment in Central and Eastern Europe: a dose of reality. Eur. J. Health Econ. 13(5), 525–531 (2012)

    Article  PubMed  Google Scholar 

  34. Krol, M., Brouwer, W., Rutten, F.: Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics 31(7), 537–549 (2013)

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors do not have any competing interest.

Author information

Authors and Affiliations

  1. 1st Department of Medicine, Semmelweis University, Korányi Sándor utca 2/A, 1083, Budapest, Hungary

    Mandel D. Michael, Barbara D. Lovász, Petra A. Golovics, Zsuzsanna Kürti, Blanka K. Szilágyi, Anna Mohás & Péter L. Lakatos

  2. 1st Department of Medicine, University of Szeged, Korányi fasor 8-10, 6720, Szeged, Hungary

    Anita Bálint, Klaudia Farkas & Tamás Molnár

  3. Department of Health Economics, Corvinus University of Budapest, Fővám tér 8, 1093, Budapest, Hungary

    László Gulácsi & Bálint Strbák

Authors
  1. Mandel D. Michael
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anita Bálint
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara D. Lovász
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. László Gulácsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bálint Strbák
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Petra A. Golovics
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Klaudia Farkas
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zsuzsanna Kürti
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Blanka K. Szilágyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Anna Mohás
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tamás Molnár
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Péter L. Lakatos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Péter L. Lakatos.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Michael, M.D., Bálint, A., Lovász, B.D. et al. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. Eur J Health Econ 15 (Suppl 1), 121–128 (2014). https://doi.org/10.1007/s10198-014-0603-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-014-0603-7

Keywords

JEL Classification

Search

Navigation